Molina Healthcare, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-96.2% vs price
Base Case (Median)
-69.2% vs price
Bull Case (75th pct.)
-15.9% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $-77.87 | -138.4% | High (40%) |
| PE Comparable | $4.23 | -97.9% | Medium (25%) |
| Graham Number | $18.51 | -90.9% | Medium (40%) |
| EV/EBITDA | $192.15 | -5.4% | Medium (20%) |
| EV/FCF | $106.71 | -47.5% | Medium (20%) |
| Earnings Power Value | $335.16 | 65.1% | Medium (50%) |
Based on 6 out of 8 methods, MOH appears overvalued at the current price of $203.06. The base case fair value of $62.61 implies 69.2% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.